EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 30, 2013

Primary Completion Date

September 22, 2017

Study Completion Date

December 31, 2017

Conditions
Breast Cancer
Interventions
DRUG

Nab-paclitaxel

comparison of different dosages of drug

Trial Locations (14)

20141

Istituto Europeo Oncologia, Milan

24127

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo

25125

Spedali Civili Brescia, Brescia

27100

Fondazione Maugeri, Pavia

33081

Centro Di Riferimento Oncologico, Aviano

33100

A.O.U. S. Maria Della Misericordia Di Udine, Udine

35128

Istituto Oncologico Veneto, Padua

37126

Ospedale Civile Maggiore, Verona

50053

Ausl 12 Viareggio, Lucca

60100

A.O.U. Ospedali Riuniti, Ancona

72100

Ospedale Antonio Perrino, Brindisi

73100

Ospedale Vito Fazzi, Lecce

80131

A.O.U. Federico Ii Di Napoli, Napoli

09039

Ospedale Ss. Trinita', Frosinone

All Listed Sponsors
lead

Fondazione Sandro Pitigliani

OTHER

NCT02783222 - EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer | Biotech Hunter | Biotech Hunter